Afatinib use in recurrent epithelial ovarian carcinoma

Amanda L. Shepherd-Littlejohn, Wyatt J. Hanft, Vanessa A Kennedy, Edwin A. Alvarez

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)70-72
Number of pages3
JournalGynecologic Oncology Reports
Volume29
DOIs
StatePublished - Aug 1 2019

Keywords

  • Afatinib
  • ERBB2
  • HER2/neu
  • Molecular tumor testing
  • Ovarian cancer
  • Targeting agents

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this